Brain zap test may spot dementia early in Parkinson's
NCT ID NCT06835595
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study uses a non-invasive brain stimulation technique called TMS to measure brain activity in 52 people with Parkinson's disease. The goal is to see if these measurements can tell the difference between normal thinking, mild cognitive impairment, and dementia, and predict future decline. No treatment is given—only observation and testing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
SC Clinica Neurologica - Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI)
NOT_YET_RECRUITINGTrieste, Friuli Venezia Giulia, Italy
-
UOC Neurologia - Azienda Provinciale per i Servizi Sanitari (APSS)
RECRUITINGTrento, Trentino-Alto Adige, 38122, Italy
-
UOC Neuroriabilitazione - Azienda Sanitaria dell'Alto Adige
NOT_YET_RECRUITINGSterzing, Trentino-Alto Adige, 39049, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Planning ahead: could a simple program transform Parkinson's care?
- Sound waves vs. Parkinson's: can ultrasound calm tremors and stiffness?
- Can a nudge in your chart unlock Life-Saving genetic clues?
- Can MRI reveal the Brain's response to deep brain stimulation?
- Can we outsmart Gaucher's hidden toll on lungs, bones, and brain?
- Could a brain disease change behavior years before diagnosis?